Bill Doyle of Novocure, a company that developed non-invasive technology to control cell division in glioblastoma tumors, spoke at TEDMED 2012 about the role low-intensity alternating electric fields can have on cancer therapy:
This post also appears on medGadget, an Atlantic partner site.
This article available online at:
http://www.theatlantic.com/health/archive/2012/02/using-low-intensity-electric-fields-as-a-form-of-cancer-therapy/252541/
